Navigation Links
FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT
Date:6/2/2010

ce asthma control is achieved and maintained, assess the patient at regular intervals and step down therapy (e.g., discontinue SYMBICORT) if possible without loss of asthma control and maintain the patient on a long-term asthma control medication, such as an inhaled corticosteroid. Do not use SYMBICORT for patients whose asthma is adequately controlled on low or medium dose inhaled corticosteroids.

SYMBICORT is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms.

Particular care is needed for patients who are transferred from systemically active corticosteroids to inhaled corticosteroids. Deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to less systemically available inhaled corticosteroids.

Patients who are receiving SYMBICORT should not use additional formoterol or other long-acting inhaled beta2-agonists for any reason.

Caution should be exercised when considering the coadministration of SYMBICORT with long-term ketoconazole and other known potent CYP3A4 inhibitors.

Excessive beta-adrenergic stimulation has been associated with central nervous system and cardiovascular effects. SYMBICORT, like all products containing sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension.

Long-term use of orally inhaled corticosteroids, such as budesonide, a component of SYMBICORT, may affect normal bone metabolism resulting in a loss of bone mineral density.

Glaucoma, increased intraocular pressure, and cataracts have been reported following the inhaled administration of corticosteroids, including budesonide, a component o
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
3. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
4. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
5. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. BioCryst Updates Peramivir Clinical Development Plan
8. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
9. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
10. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
11. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... 31, 2015 Noser Health ... to deliver new platform ... citizen-owned health data transaction platform, announced today strategic partnerships ... to engineer and bring to market its global health ... "Our business model is built on trust, ...
(Date:8/28/2015)... 28, 2015  CytomX Therapeutics, Inc., a biopharmaceutical company ... announced the filing of a registration statement on Form ... relating to a proposed initial public offering of its ... and the price range for the offering have not ... stock under the symbol "CTMX" on the NASDAQ Global ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
Breaking Medicine Technology:healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 2healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 3healthbank Announces Strategic Partnerships to Bring to Market Global Health Data Transaction Platform 4CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Tobramycin Market, 2015-2019 2
... 16 Metabolic Solutions Development Company (MSDC), www.msdrx.com ... the Study of Diabetes (EASD) annual conference in Stockholm, ... the company,s clinical candidate, MSDC-0160, promotes the proliferation of ... creation of more brown fat.  The research was conducted ...
... LOS ANGELES, Sept. 16 Canon Communications LLC ... United Business Media Limited, a leading global business ... LLC , the management/investment company of Canon Chairman and CEO ... private equity partner.  Apprise and Spectrum acquired Canon in 2005. ...
Cached Medicine Technology:Metabolic Solutions Development Company to Present Research Findings to European Association for the Study of Diabetes 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 2Canon Communications to be Sold to United Business Media; Transaction Expands Global Reach of Canon's Advanced Manufacturing and Design Focus 3
(Date:8/30/2015)... ... 30, 2015 , ... AvePoint, the established leader ... Silver Sponsor of the Digital Workplace Conference, taking place Sunday, August 30 – ... the event, AvePoint will showcase its file analysis, management, and migration solutions for ...
(Date:8/30/2015)... ... August 30, 2015 , ... Scientists in France say asbestos exposure may put ... cancers. Surviving Mesothelioma has just posted an article on the new research. Click ... the cancer incidence among 2,024 French asbestos plant workers from 1978 to 2009. In ...
(Date:8/30/2015)... ... August 30, 2015 , ... Natural Rest contains a unique ... sleep aids and calming remedies, which help to improve mood disorders and anxiety. Like ... deal of research in the field of regenerative medicine conducted by Dr. Amit Patel ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products ... lead the expansion of global cosmeceutical and skin care brands. Mr. Fernandez ... the last 25 years working in operations, purchasing and management for some of ...
(Date:8/30/2015)... ... August 30, 2015 , ... ... medical devices for the treatment of prostate cancer, has announced the roll-out of ... at the treatment center in Puerto Vallarta, Mexico. , The Sonablate® technology currently ...
Breaking Medicine News(10 mins):Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2
... WASHINGTON, March 23 Four Miami-area residents pleaded guilty ... scheme involving HIV infusion clinics, Acting Assistant Attorney General ... Attorney R. Alexander Acosta of the Southern District of ... Garrido, 69; Gonzalo Nodarse, 38; and Alexis Carrazana, 41; ...
... The Board of Directors of the Radiological Society of ... Watson will become the Society,s executive director on April 1, ... of experience working in key capacities at RSNA and has ... Assistant executive director for finance and administration at RSNA for ...
... for the Cure(R) Advocacy Alliance commended Reps. Debbie Wasserman Schultz ... and Melissa Bean (D-IL) for their efforts to inspire young ... introduction today of the "Breast Cancer E ducation and ... Y oung Act of 2009." The EARLY Act will ...
... Research with canines may one day lead to new therapies ... Joe Bauer got the call on a Friday afternoon. , ... adenocarcinoma, a particularly virulent cancer in dogs, and had been ... owners, from Milford, Mass., were heartbroken and planned to have ...
... A new study published in Epilepsia reveals ... relatively safe and is effective in controlling seizures. The ... positive impact on babies, brain development. , The study ... age across all pediatric neurosurgical centers in Canada between ...
... The US back pain market for drug treatment will ... US Back Pain, a report released today by WWMR, Inc. ... the opioid agonist products that are currently in development. ... anticipated in the clinical community. If pipeline products deliver ...
Cached Medicine News:Health News:Two Doctors and Two Medical Assistants Plead Guilty in $10 Million Medicare Fraud Scheme 2Health News:Two Doctors and Two Medical Assistants Plead Guilty in $10 Million Medicare Fraud Scheme 3Health News:Mark G. Watson Named Executive Director of Radiological Society of North America 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Supports Effort to Encourage Early Breast Health Education 2Health News:Dogs Help in Hunt for New Cancer Drugs 2Health News:Dogs Help in Hunt for New Cancer Drugs 3Health News:Surgery safe for babies and toddlers suffering from seizures 2Health News:US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting, Abuse-Resistant Opioids Drive Value 2Health News:US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting, Abuse-Resistant Opioids Drive Value 3
... Designed with patient need and ... Orthotic Appliance) family of products effectively ... indications. The Chairback frame attachment provides ... orthosis (LSO) provides superior support for ...
Effectively stabilize and relax your back with the LumboTrain back support....
... to superior immobilization and cervical spine care, one ... already know that the most important function of ... But what you may not know is that ... provides superior immobilization over the leading one-piece rigid ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
Medicine Products: